SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

Recruiting now

Conditions studied: Parkinson Disease

In brief

The purpose of the study is to generate real-world evidence data for the on-demand treatment with SL-APO, focusing on understanding its usage and titration practices including individual dose determination after dose-adjustment to ultimately understand their influence in patient satisfaction, treatment persistence, and the balance between effectiveness and safety. The data may help optimize titration approaches to better meet the patient's needs.

Key facts

Study ID
NCT07145190
Run by
Bial - Portela C S.A.
People needed
90
Starts
2025-08-27
Expected to finish
2028-02-01
Last updated by the study team
2026-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.